Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1903 1
1906 1
1947 2
1953 1
1959 1
1962 1
1964 2
1965 2
1966 3
1967 2
1968 3
1969 2
1970 2
1971 2
1972 2
1973 2
1974 4
1975 12
1976 11
1977 18
1978 21
1979 38
1980 26
1981 22
1982 27
1983 31
1984 41
1985 35
1986 31
1987 25
1988 28
1989 29
1990 16
1991 30
1992 20
1993 21
1994 16
1995 30
1996 38
1997 27
1998 28
1999 26
2000 32
2001 41
2002 44
2003 48
2004 44
2005 50
2006 72
2007 62
2008 73
2009 83
2010 68
2011 83
2012 79
2013 77
2014 61
2015 83
2016 73
2017 85
2018 54
2019 69
2020 65
2021 57
2022 79
2023 66
2024 111
2025 112
2026 56

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,347 results

Results by year

Filters applied: . Clear all
Page 1
Benzoyl peroxide.
[No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risks Hum. 1999;71 Pt 2(PT 2):345-58. IARC Monogr Eval Carcinog Risks Hum. 1999. PMID: 10476451 Free PMC article. Review. No abstract available.
Adapalene/benzoyl peroxide gel 0.3%/2.5% for acne vulgaris.
Dréno B, Layton AM, Troielli P, Rocha M, Chavda R. Dréno B, et al. Eur J Dermatol. 2022 Jul 1;32(4):445-450. doi: 10.1684/ejd.2022.4275. Eur J Dermatol. 2022. PMID: 36301750 Review. English.
Adapalene, a synthetic topical retinoid, is available in two concentrations (0.1% and 0.3%) and in once-daily fixed-dose combinations with benzoyl peroxide (BPO) 2.5%. Adapalene 0.3%/BPO 2.5% is approved for use for moderate-to-severe acne with proven efficacy, good …
Adapalene, a synthetic topical retinoid, is available in two concentrations (0.1% and 0.3%) and in once-daily fixed-dose combinations with …
Benzoyl peroxide: an integrated human safety assessment for carcinogenicity.
Kraus AL, Munro IC, Orr JC, Binder RL, LeBoeuf RA, Williams GM. Kraus AL, et al. Regul Toxicol Pharmacol. 1995 Feb;21(1):87-107. doi: 10.1006/rtph.1995.1014. Regul Toxicol Pharmacol. 1995. PMID: 7784640 Review.
Topical benzoyl peroxide has been used in the treatment of acne for over 30 years, with no reports of adverse effects that could be related to skin carcinogenesis. Two case-control epidemiological studies have found a lack of association between the specific use of …
Topical benzoyl peroxide has been used in the treatment of acne for over 30 years, with no reports of adverse effects that cou …
Benzoyl Peroxide Drug Products Form Benzene.
Kucera K, Zenzola N, Hudspeth A, Dubnicka M, Hinz W, Bunick CG, Dabestani A, Light DY. Kucera K, et al. Environ Health Perspect. 2024 Mar;132(3):37702. doi: 10.1289/EHP13984. Epub 2024 Mar 14. Environ Health Perspect. 2024. PMID: 38483533 Free PMC article. No abstract available.
Benzoyl peroxide.
Cotterill JA. Cotterill JA. Acta Derm Venereol Suppl (Stockh). 1980;Suppl 89:57-63. Acta Derm Venereol Suppl (Stockh). 1980. PMID: 6162349 Clinical Trial.
The mode of action of benzoyl peroxide in acne is three-fold, i.e. sebostatic, comedolytic and inhibitory to P. acnes in-vivo. Benzoyl peroxide is the topical treatment of choice in acne vulgaris. This agent is well tolerated by most patients. ...
The mode of action of benzoyl peroxide in acne is three-fold, i.e. sebostatic, comedolytic and inhibitory to P. acnes in-vivo. …
Tretinoin 0.1% and Benzoyl Peroxide 3% Cream for the Treatment of Facial Acne Vulgaris.
Kontzias C, Zaino M, Feldman SR. Kontzias C, et al. Ann Pharmacother. 2023 Sep;57(9):1088-1093. doi: 10.1177/10600280221147338. Epub 2023 Jan 13. Ann Pharmacother. 2023. PMID: 36639853
OBJECTIVE: To assess the efficacy, safety, and clinical application of tretinoin 0.1%-benzoyl peroxide 3% cream for the topical treatment of acne vulgaris. DATA SOURCES: A systematic review of the literature was performed using the terms Twyneo OR tretinoin and b …
OBJECTIVE: To assess the efficacy, safety, and clinical application of tretinoin 0.1%-benzoyl peroxide 3% cream for the topica …
Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
Sagransky M, Yentzer BA, Feldman SR. Sagransky M, et al. Expert Opin Pharmacother. 2009 Oct;10(15):2555-62. doi: 10.1517/14656560903277228. Expert Opin Pharmacother. 2009. PMID: 19761357 Review.
BACKGROUND: Owing to the use of topical and systemic antibiotics for acne vulgaris, the incidence of antibiotic-resistant Propionibacterium acnes is increasing worldwide. Topical benzoyl peroxide (BPO) is an alternative to antibiotics in the treatment of acne vulgar …
BACKGROUND: Owing to the use of topical and systemic antibiotics for acne vulgaris, the incidence of antibiotic-resistant Propionibacterium …
Clindamycin/benzoyl peroxide gel: a review of its use in the management of acne.
Warner GT, Plosker GL. Warner GT, et al. Am J Clin Dermatol. 2002;3(5):349-60. doi: 10.2165/00128071-200203050-00007. Am J Clin Dermatol. 2002. PMID: 12069641 Review.
Clindamycin/benzoyl peroxide gel applied twice daily was well tolerated in clinical trials in patients with acne, and has a tolerability profile similar to that of benzoyl peroxide alone. ...Clindamycin/benzoyl peroxide was more effective …
Clindamycin/benzoyl peroxide gel applied twice daily was well tolerated in clinical trials in patients with acne, and has a to …
Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne.
McKeage K, Keating GM. McKeage K, et al. Am J Clin Dermatol. 2008;9(3):193-204. doi: 10.2165/00128071-200809030-00010. Am J Clin Dermatol. 2008. PMID: 18429651 Review.
In well designed clinical trials in patients with mild to moderately severe acne, the efficacy of once- or twice-daily clindamycin/benzoyl peroxide in the reduction of inflammatory lesion counts was greater than that of benzoyl peroxide alone, clindamy …
In well designed clinical trials in patients with mild to moderately severe acne, the efficacy of once- or twice-daily clindamycin/benzoy …
2,347 results